Cite
Figure Legends from Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab
MLA
Tara C. Gangadhar, et al. Figure Legends from Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22468544.
APA
Tara C. Gangadhar, Keaven M. Anderson, Scot Ebbinghaus, S. Peter Kang, Jin Zhang, Andrea Perrone, Dinesh P. de Alwis, Amita Patnaik, Jeffrey S. Weber, Peter Hersey, Roxana Dronca, Adil Daud, Caroline Robert, Omid Hamid, F. Stephen Hodi, Antoni Ribas, Anthony M. Joshua, Jedd D. Wolchok, Wen-Jen Hwu, … Richard W. Joseph. (2023). Figure Legends from Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab. https://doi.org/10.1158/1078-0432.22468544
Chicago
Tara C. Gangadhar, Keaven M. Anderson, Scot Ebbinghaus, S. Peter Kang, Jin Zhang, Andrea Perrone, Dinesh P. de Alwis, et al. 2023. “Figure Legends from Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab,” March. doi:10.1158/1078-0432.22468544.